Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized comparison of TPIAO to no treatment for platelet recovery after haploidentical hematopoietic stem cell transplantation
ChiCTR-TRC-11001774Phase 4Completed
- Sponsor
- Peking University Institute of Hematology
- Start
- Nov 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of recombinant human thrombopoietin in hematopoietic malignancies (2 arms), sponsored by Peking University Institute of Hematology. Primary endpoint: Incidence of platelet engraftment. Started Nov 2010; status: completed.
02
Drugs
recombinant human thrombopoietin
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on ChiCTR-TRC-11001774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001774.